A Phase II Study of Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer.
Phase of Trial: Phase II
Latest Information Update: 12 Nov 2013
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary)
- Indications Endometrial cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Nov 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Aug 2013 Planned end date changed from 1 Aug 2014 to 1 Aug 2015 as reported by ClinicalTrials.gov.